1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Condition(s):Metastatic Breast CancerLast Updated:May 27, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast CancerLast Updated:May 27, 2022Terminated
Condition(s):EndometriosisLast Updated:April 23, 2007Completed
Condition(s):Breast CancerLast Updated:July 13, 2016Completed
Condition(s):Hormono-depending Adjuvant Breast CancerLast Updated:March 2, 2018Completed
Condition(s):Breast CancerLast Updated:March 11, 2009Completed
Condition(s):Breast CancerLast Updated:March 18, 2024Active, not recruiting
Condition(s):Healthy VolunteersLast Updated:April 26, 2021Completed
Condition(s):HypertensionLast Updated:October 19, 2017Withdrawn
Condition(s):Breast CancerLast Updated:January 24, 2019Completed
Condition(s):Breast CancerLast Updated:April 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.